Table 1 Characteristics of normal and myopic eyes with each stage of glaucoma

Number of eyes

21

28

39

18

23

-

-

Age (years)

57.7 ± 7.4

54.8 ± 6.2

54.5 ± 7.6

51.8 ± 9.1

55.3 ± 7.7

0.23^a

0.48^a

Sex (M:F)

12 : 9

17 : 11

22 : 17

13 : 5

13 : 10

0.82^b

0.69^b

SBP (mmHg)

123.911.8

128.0 ± 16.3

125.2 ± 14.5

126.7 ± 13.3

128.3 ± 19.6

0.84^a

0.87^a

DBP (mmHg)

74.0 ± 8.9

77.9 ± 12.4

75.9 ± 15.0

79.6 ± 15.1

81.2 ± 16.2

0.43^a

0.56^a

Hypertension medications (n, %)

-

2, 7.1

3, 7.7

0, 0

4, 17.3

-

0.10^b

Glaucoma medications (n, %)

-

-

-

-

-

-

0.51^b

 Prostaglandin analogues

-

-

27, 69.2

14, 77.8

21, 91.3

-

-

 Beta-anatagonists

-

-

10, 25.6

7, 38.9

13, 56.5

-

-

 Carbonic anhydrase inhibitors

-

-

12, 30.8

5, 27.8

9, 39.1

-

-

 Alpha-1-anatagonists

-

-

4, 10.3

2, 11.1

10, 43.5

-

-

IOP (mmHg)

13.0 ± 2.8

14.7 ± 2.8

17.0 ± 4.5

17.9 ± 6.3

17.4 ± 3.8

<.001^a

0.05^a

Spherical equivalent (D)

-1.5 ± 2.5

-3.1 ± 2.3

-4.4 ± 3.0

-6.0 ± 2.4

-5.0 ± 2.4

0.003^a

0.003^a

MD (dB)

0.8 ± 0.9

0.05 ± 1.1

-3.2 ± 1.8

-8.6 ± 1.2

-20.1 ± 3.7

<.001^a

<.001^a

CpRNFLT (μm)

118.3 ± 9.6

99.7 ± 11.6

84.3 ± 16.5

75.3 ± 15.0

61.3 ± 10.0

<.001^a

<.001^a

MBR (AU)

31.1 ± 4.0

26.3 ± 5.1

21.9 ± 5.4

18.2 ± 4.0

16.8 ± 4.6

<.001^a

<.001^a